CUV 0.00% $14.30 clinuvel pharmaceuticals limited

marching, page-15

  1. 22,691 Posts.
    Agree, it doesn't need ramping; it should stand on its own feet and it does.

    The stock has been held back for a considerable time while trials have been proceeding.

    The one to look forward to is the PMLE trial in Northern Europe. A pity it is still some time before we see it.

    But I am relying on much publicity at that time, as was mentioned before.

    Info on EPT:
    http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=61463&sym=EPT#156349


    Gerry
    Readers, please do your own research and you decide if and when to buy, hold or sell any stocks.

 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.